Injectable Polymer Scaffold Composition for Minimally Invasive Tissue Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing tissue scaffolds require invasive surgical procedures for implantation, as they need to be prefabricated to a specific shape and size, which limits their application and convenience.

Innovation Solution

A composition of polymer particles and a carrier, where the polymer particles are a mixture of at least two polymers with a glass transition temperature lower than the second polymer, allowing them to join and form a scaffold in vivo without pre-shaping, administered via injection to conform to the tissue cavity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If tissue scaffolds are prefabricated to a specific shape and size, then they can be used for tissue repair, but invasive surgical procedures are required for implantation

Engineering Contradiction:
Improvescaffold shape and sizeVSAvoidimplantation procedure
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The invention changes the physical state parameter of the scaffold material from solid to liquid/slurry form, enabling injection through a needle. The scaffold material is formulated as a suspension or slurry that can be administered minimally invasively, then transforms back to a solid structure in situ, resolving the contradiction between manufacturing precision and ease of operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The scaffold material undergoes a phase transition from liquid/slurry state during injection to solid state after implantation. This phase change enables the material to be delivered via simple injection procedures while still forming a structurally precise scaffold in the target tissue site

Inventive Principle:
Principle #36Phase transitions

2Strength

If tissue scaffolds are prefabricated to a specific shape and size, then they can provide structural support, but the surgical procedure becomes more complex

Engineering Contradiction:
Improvescaffold structural supportVSAvoidsurgical procedure
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The invention changes the physical state parameter of the scaffold material from solid to liquid/slurry form, enabling injection through a needle. The scaffold material is formulated as a suspension or slurry that can be administered minimally invasively, then transforms back to a solid structure in situ, resolving the contradiction between manufacturing precision and ease of operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The scaffold material undergoes a phase transition from liquid/slurry state during injection to solid state after implantation. This phase change enables the material to be delivered via simple injection procedures while still forming a structurally precise scaffold in the target tissue site

Inventive Principle:
Principle #36Phase transitions

3Reliability

If tissue scaffolds are made from synthetic materials, then they can provide structural framework, but the need for invasive surgery remains

Engineering Contradiction:
Improvescaffold structural frameworkVSAvoidimplantation method
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention changes the physical state parameter of the scaffold material from solid to liquid/slurry form, enabling injection through a needle. The scaffold material is formulated as a suspension or slurry that can be administered minimally invasively, then transforms back to a solid structure in situ, resolving the contradiction between manufacturing precision and ease of operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The scaffold material undergoes a phase transition from liquid/slurry state during injection to solid state after implantation. This phase change enables the material to be delivered via simple injection procedures while still forming a structurally precise scaffold in the target tissue site

Inventive Principle:
Principle #36Phase transitions

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the formation of a scaffold that conforms to the tissue site, overcoming the need for invasive surgery and providing improved hardness and strength, suitable for tissue repair and regeneration.

Implementation Method 1

the first polymer is at least partially soluble or dispersible in the carrier

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

the first polymer is at least partially soluble or dispersible in the carrier... the mixture of the two polymers has a glass transition temperature lower than the glass transition temperature of the second type of polymer on its own

Methodology Applied
Scientific EffectPlasticization:

Implementation Method 3

The joining together of the polymer particles may be due to, for example, one or more of fusion, adhesion, cohesion and entanglement of the polymer and/or particles

Methodology Applied
Scientific EffectFusion:

Implementation Method 4

The joining together of the polymer particles may be due to, for example, one or more of fusion, adhesion, cohesion and entanglement of the polymer and/or particles

Methodology Applied
Scientific EffectAdhesion: Adhesive

Implementation Method 5

the polymer particles are arranged such that they can join together to form a scaffold of polymer particles... formation of the scaffold from the particles in the composition may be referred to as solidification

Methodology Applied
Scientific EffectSolidification: Phase Change

Data Source

PatentUS10195309B2Injectable scaffold composition
Publication Date: 2019.02.05 REGENTEC
  • US10195309B2 patent drawing
  • US10195309B2 patent drawing
  • US10195309B2 patent drawing

AI summary

A composition comprising polymer particles and a carrier, wherein the polymer particles are a mixture of at least a first polymer and a second polymer, wherein the first polymer is at least partially soluble or dispersible in the carrier, and wherein the polymer particles are arranged such that they can join together to form a scaffold of polymer particles, and wherein the composition is administrable to a human or non-human animal.